BioMed Research International / 2019 / Article / Tab 1 / Research Article
Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study Table 1 Patients’ characteristics.
Characteristics No. of patients % Age (median range) 49 11-83 Gender Male 129 73.7 Female 46 26.3 WHO performance status 0 79 45.1 1 96 54.9 Treatment Induction chemotherapy+ 116 66.3 concurrent chemoradiotherapy Induction chemotherapy+ 54 30.9 concurrent chemoradiotherapy+ molecular targeted therapy Concurrent chemoradiotherapy+ 1 0.6 molecular targeted therapy Concurrent chemoradiotherapy 2 1.1 Radiotherapy alone 2 1.1 Tumor site Oropharynx 5 2.86 Nasopharynx 128 73.14 Hypopharynx 20 11.43 Larynx 7 4.00 Oral cavity 9 5.14 Nasal cavity and paranasal sinuses 4 2.29 Others 2 1.14 T-stage T1 17 9.7 T2 61 34.9 T3 37 21.1 T4 38 21.7 T4a 14 8.0 T4b 8 4.6 N-stage N0 26 14.9 N1 34 19.4 N2 95 54.3 N3 20 11.4 UICC/AJCC (2010) II 23 13.14 III 60 34.29 IVa 65 37.14 IVb 27 15.43